Head-to-head · WeighScore
Alloy vs NuuVim
The verdict
Alloy takes it — 72/100 to 71.1/100, but only just.
Alloy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide… NuuVim is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Alloy | NuuVim |
|---|---|---|
| WeighScore | 72/100 | 71.1/100 |
| Grade | C | C |
| Scorecard rank | #84 | #101 |
| Semaglutide | $169/mo (compounded) | $79/mo (all doses, compounded) |
| Tirzepatide | $199/mo (compounded) | $133/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #84 · C
Strengths
- Broadest GLP-1 formulary here: brand Wegovy and Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide, and liraglutide
- All consulting doctors are certified by The Menopause Society — a rare credential
- STARTGLP1 promo code takes $50 off the first month
- Spans the price range: compounded semaglutide from $70/mo, brand Wegovy from $199/mo (each plus the $99/mo Weight Care fee)
Where it loses points
- Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
- A mandatory $99/mo Alloy Weight Care fee sits on top of every medication price (so the true minimum is ~$169/mo, not $70)
- Compounded semaglutide not available in AL, AR, CA, NV, LA, MS or DC
Graded #101 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- No founder, CEO, medical director, or pharmacist-in-charge named
- Refund and cancellation policy not surfaced on the site
- Compounded medications are not FDA-approved
- Doesn't disclose which pharmacy fills which drug or form
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.